Literature DB >> 15471908

Combating atherosclerosis with LXR alpha and PPAR alpha agonists: is rational multitargeted polypharmacy the future of therapeutics in complex diseases?

Tomoshige Kino1, George P Chrousos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15471908     DOI: 10.1124/mi.4.5.5

Source DB:  PubMed          Journal:  Mol Interv        ISSN: 1534-0384


× No keyword cloud information.
  1 in total

Review 1.  Isolated low high density lipoprotein-cholesterol (HDL-C): implications of global risk reduction. Case report and systematic scientific review.

Authors:  Melvin R Hayden; Suresh C Tyagi
Journal:  Cardiovasc Diabetol       Date:  2005-01-04       Impact factor: 9.951

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.